MAPK9 and breast carcinoma: As far as it regards JNK inhibitors in the control of cell migration and invasion, it has been reported that JNK2-selective peptide inhibitors inhibited breast cancer cell migration [32] and that JNK suppression inhibited cell migration in human LoVo colon cancer cells [33].